Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium–glucose cotransporter 2 inhibitor: a retrospective database study

Dominik Lautscha Center for Observational and Real-World Evidence, Merck & Co., Inc, Kenilworth, NJ, USACorrespondence[email protected]

Kristy Iglaya Center for Observational and Real-World Evidence, Merck & Co., Inc, Kenilworth, NJ, USA

Lingfeng Yanga Center for Observational and Real-World Evidence, Merck & Co., Inc, Kenilworth, NJ, USA

Neha Bansalb Complete HEOR Solutions (CHEORS), North Wales, PA, USA

Riddhi Markanb Complete HEOR Solutions (CHEORS), North Wales, PA, USA

Niranjan Katheb Complete HEOR Solutions (CHEORS), North Wales, PA, USA

Swapnil Rajpathaka Center for Observational and Real-World Evidence, Merck & Co., Inc, Kenilworth, NJ, USA

Your download is now in progress and you may close this window